BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, June 8, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 28, 2009

View Archived Issues

Computational biology approach indicates potential for entacapone in tuberculosis

Read More

Locus Pharmaceuticals selects novel allosteric p38 inhibitor for development

Read More

Program at TetraLogic yields Smac mimetics with antitumor activity

Read More

Nociceptin receptor agonist from Schering-Plough displays antitussive activity in vivo

Read More

Dyax presents update on licensing and funded research program

Read More

Resverlogix reports results from phase Ib/IIa RVX-208 study for atherosclerosis

Read More

EMEA approves Huntexil as trade name for NeuroSearch's pridopidine for HD

Read More

Astellas and Pfizer sign copromotion agreement for Caduet

Read More

Chugai reports results from second quarter 2009

Read More

Diamyd to include children and accelerate recruitment in phase III diabetes trial

Read More

Endo to partner with ProStrakan to commercialize Fortesta in the U.S.

Read More

Wyeth tests novel 5-HT1A antagonists for cognitive enhancement

Read More

Amgen reports on oncolytic small-molecule Smoothened antagonists

Read More

Genmab reports topline results for Arzerra in non-Hodgkin's lymphoma

Read More

NIAID awards grant to expand studies of anti-PS antibodies for hemorrhagic fevers

Read More

EMEA accepts for review Schering-Plough's MAAs for asthma drug and contraceptive

Read More

Silence Therapeutics enters siRNA delivery collaboration with Dainippon Sumitomo

Read More

UCB and Immunomedics report topline results from phase IIb epratuzumab study in SLE

Read More

Gruenenthal discloses novel bradykinin B1 receptor antagonists for pain treatment

Read More

RNA-directed RNA polymerase (NS5B) inhibitors patented by Tibotec

Read More

Merck Serono claims protein kinase inhibitors for cancer, inflammatory disorders

Read More

Novel beta-lactams in early development at Allergan

Read More

Lactam inhibitors of 11-beta-HSD1 presented by Vitae Pharmaceuticals

Read More

Novel orexin receptor antagonists identified at Roche

Read More

Oxagen develops CRTH2 receptor antagonists for treating allergic diseases

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 8, 2026.
  • New York University identifies new analogues of mannose-6-phosphate

    BioWorld Science
    New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
  • China compass

    ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins

    BioWorld
    If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
  • Bial-Portela discovers new OX1 receptor antagonists

    BioWorld Science
    Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
  • Liver disease

    FB-7033 demonstrates efficacy in MASH management

    BioWorld Science
    17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing